Geriatricians should note implications of updated Menopause Hormone Therapy guidelines post FDA warning removal.
A New Era for Menopause Hormone Therapy: Key Considerations for Geriatricians After FDA Boxed Warning Removal.
No takes yet. Share an insight, caveat, or question.
Hanfling et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: